The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
970
March 15, 1996
View Complete Issue         Table of Contents 2019 
Ceftibuten - A New Oral Cephalosporin
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Ceftibuten - A New Oral Cephalosporin
March 15, 1996 (Issue: 970)
Ceftibuten (Cedax - Schering), an oral cephalosporin similar to cefixime (Suprax - Medical Letter, 31:73, 1989), has been approved by the US Food and Drug Administration (FDA) for treatment of acute otitis media, pharyngitis or tonsillitis, and for...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Ceftibuten - A New Oral Cephalosporin
Article code: 970b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.